Thermo Fisher Scientific Zalutumumab Recombinant Human Monoclonal Antibody (2F8 (Zalutumumab; HuMax-EGFR))

Applications

Tested Dilution

Publications

Western Blot (WB)

Assay-dependent

-

Flow Cytometry (Flow)

Assay-dependent

-

ELISA (ELISA)

Assay-dependent

-

Product Specifications

Species Reactivity

Human

Host/Isotype

Human / IgG1, kappa

Expression System

HEK293 cells

Class

Recombinant Monoclonal

Type

Antibody

Clone

2F8 (Zalutumumab; HuMax-EGFR)

Immunogen

The original monoclonal antibody was generated by immunizing HuMAb mice with alternating A431 cells and purified EGFR administration.

Conjugate

Unconjugated Unconjugated Unconjugated

Form

Liquid

Concentration

1 mg/mL

Purification

Protein A

Storage buffer

PBS

Contains

0.02% ProClin 300

Storage conditions

Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles.

Shipping conditions

Wet ice

Product Specific Information

This antibody binds domain III of the human epidermal growth factor receptor (EGFR).

Target Information

Zalutumumab is a fully human IgG1 monoclonal antibody designed to bind with selectivity to the epidermal growth factor receptor (EGFR). Zalutumumab has been investigated for the treatment of Squamous Cell Cancer and Head and Neck Cancer.

For Research Use Only. Not for use in diagnostic procedures. Not for resale without express authorization.